In conclusion, this study indicated that IGFBP7 has important clinical significance in GC and is associated with immune cell infiltration, such as that of cancer‐related fibroblasts, and the sensitivity to antitumor drugs, such as erlotinib. The gene discussed is IGFBP7; the disease is cancer.